SBI Securities’s Petros Pharmaceuticals PTPI Stock Holding History

SBI Securities’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13	Closed	-$22	–	4213
2025 Q1	$22	Buy	+13	New	+$66	﹤0.01%	3835

SBI Securities's PTPI Position: Q2 2025 in Review

SBI Securities sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 13 shares — an estimated $22 sold.

SBI Securities first reported a position in PTPI in Q1 2025 and held it in 1 quarter. The position peaked at $22 in Q1 2025. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

SBI Securities reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 13 Petros Pharmaceuticals shares in Q2 2025, an estimated $22.
SBI Securities first reported a position in Petros Pharmaceuticals in Q1 2025 and held it in 1 quarter.
SBI Securities's Petros Pharmaceuticals position peaked at $22 in Q1 2025.
0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.